Silvio Dionisotti

1.7k total citations
43 papers, 1.5k citations indexed

About

Silvio Dionisotti is a scholar working on Physiology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Silvio Dionisotti has authored 43 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Physiology, 27 papers in Molecular Biology and 22 papers in Organic Chemistry. Recurrent topics in Silvio Dionisotti's work include Adenosine and Purinergic Signaling (31 papers), Pharmacological Receptor Mechanisms and Effects (16 papers) and Synthesis and Biological Evaluation (16 papers). Silvio Dionisotti is often cited by papers focused on Adenosine and Purinergic Signaling (31 papers), Pharmacological Receptor Mechanisms and Effects (16 papers) and Synthesis and Biological Evaluation (16 papers). Silvio Dionisotti collaborates with scholars based in Italy, Sweden and United States. Silvio Dionisotti's co-authors include Ennio Ongini, Cristina Zocchi, E. Ongini, Pier Giovanni Baraldi, Bertil B. Fredholm, Angela Monopoli, Stefania Gessi, Giampiero Spalluto, Eva Irenius and Barbara Cacciari and has published in prestigious journals such as Circulation Research, Journal of Medicinal Chemistry and Journal of Neurochemistry.

In The Last Decade

Silvio Dionisotti

42 papers receiving 1.4k citations

Peers

Countries citing papers authored by Silvio Dionisotti

Since Specialization

Citations

This map shows the geographic impact of Silvio Dionisotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvio Dionisotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvio Dionisotti more than expected).

Fields of papers citing papers by Silvio Dionisotti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvio Dionisotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvio Dionisotti. The network helps show where Silvio Dionisotti may publish in the future.

Co-authorship network of co-authors of Silvio Dionisotti

This figure shows the co-authorship network connecting the top 25 collaborators of Silvio Dionisotti. A scholar is included among the top collaborators of Silvio Dionisotti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvio Dionisotti. Silvio Dionisotti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors 1999 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·E. Ongini, Silvio Dionisotti, Stefania Gessi, Eva Irenius, Bertil B. Fredholm	164
2	[³H]‐SCH 58261 labelling of functional A_2A adenosine receptors in human neutrophil membranes 1998 ·British Journal of Pharmacology ·(unknown), Stefania Gessi, Silvio Dionisotti, Ennio Ongini, Pier Andrea Borea	57
3	Characterization of human A_2A adenosine receptors with the antagonist radioligand [³H]‐SCH 58261 1997 ·British Journal of Pharmacology ·Silvio Dionisotti, Ennio Ongini, Cristina Zocchi, Björn Kull, (unknown), Bertil B. Fredholm	57
4	Labeling of A2A adenosine receptors in human platelets by use of the new nonxanthine antagonist radioligand [3H]SCH 58261. 1996 ·Journal of Pharmacology and Experimental Therapeutics ·Silvio Dionisotti, S. D. Ferrara, (unknown), Cristina Zocchi, E. Ongini	32
5	Neuropharmacology of the adenosine A2A receptors 1996 ·Drug Development Research ·Ennio Ongini, Silvio Dionisotti, Micaela Morelli, (unknown), Per Svenningsson, Kjell Fuxé, Bertil B. Fredholm	20
6	Synthesis of the tritium labeled SCH 58261, a new non-xanthine A2A adenosine receptor antagonist 1996 ·Journal of Labelled Compounds and Radiopharmaceuticals ·Pier Giovanni Baraldi, Barbara Cacciari, Silvio Dionisotti, (unknown), Giampiero Spalluto, Cristina Zocchi	10
7	The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist. 1996 ·Journal of Pharmacology and Experimental Therapeutics ·Cristina Zocchi, E. Ongini, Andrea Conti, Angela Monopoli, (unknown), P. G. BARALDI, Silvio Dionisotti	180
8	Binding of the radioligand [³H]‐SCH 58261, a new non‐xanthine A_2A adenosine receptor antagonist, to rat striatal membranes 1996 ·British Journal of Pharmacology ·Cristina Zocchi, Ennio Ongini, S. D. Ferrara, Pier Giovanni Baraldi, Silvio Dionisotti	77
9	2-Aralkynyl and 2-Heteroalkynyl Derivatives of Adenosine-5'-N-Ethyluronamide as Selective A2a Adenosine Receptor Agonists 1995 ·Journal of Medicinal Chemistry ·Gloria Cristalli, Emidio Camaioni, Sauro Vittori, Rosaria Volpini, Pier Andrea Borea, (unknown), Silvio Dionisotti, Ennio Ongini, Angela Monopoli	48
10	2-Alkynyl Derivatives of Adenosine-5'-N-ethyluronamide: Selective A2 Adenosine Receptor Agonists with Potent Inhibitory Activity on Platelet Aggregation 1994 ·Journal of Medicinal Chemistry ·G. Cristalli, Rosaria Volpini, Sauro Vittori, Emidio Camaioni, Angela Monopoli, (unknown), Silvio Dionisotti, Cristina Zocchi, Ennio Ongini	50
11	Effects of the new A₂ adenosine receptor antagonist 8FB‐PTP, an 8 substituted pyrazolo‐triazolo‐pyrimidine, on in vitro functional models 1994 ·British Journal of Pharmacology ·Silvio Dionisotti, (unknown), (unknown), Cristina Zocchi, F. GATTA, Ennio Ongini	31
12	Binding characteristics of the adenosine A2 receptor ligand [3H]CGS 21680 to human platelet membranes 1994 ·Biochemical Pharmacology ·Katia Varani, Pier Andrea Borea, Laura Guerra, Silvio Dionisotti, Cristina Zocchi, Ennio Ongini	11
13	Effects of adenosine derivatives on human and rabbit platelet aggregation 1992 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Silvio Dionisotti, Cristina Zocchi, Katia Varani, (unknown), Ennio Ongini	43
14	Effects of remoxipride, a dopamine D-2 antagonist antipsychotic, on sleep-waking patterns and EEG activity in rats and rabbits 1992 ·Psychopharmacology ·E. Ongini, Ping Bo, Silvio Dionisotti, (unknown), F Savoldi	15
15	Simple Measurement of Isepamicin, a New Aminoglycoside Antibiotic, in Guinea Pig and Human Plasma, Using High-Performance Liquid Chromatography with Ultraviolet Detection 1991 ·Therapeutic Drug Monitoring ·Silvio Dionisotti, (unknown), F. Scaglione, Ennio Ongini	6
16	High-performance liquid chromatographic assay of dilevalol, a β-adrenoceptor blocker, in rat and human plasma 1990 ·Journal of Chromatography B Biomedical Sciences and Applications ·Silvio Dionisotti, (unknown), Angela Monopoli	1
17	Aminoglycoside Dosing Regimen and Pharmacokinetic Parameters in the Guinea Pig 1990 ·Chemotherapy ·Silvio Dionisotti, (unknown), Peter C. K. Leung, William G. Kramer, Ennio Ongini	2
18	The impact of different dosing regimens of the aminoglycosides netilmicin and amikacin on vestibulotoxicity in the guinea pig 1990 ·European Archives of Oto-Rhino-Laryngology ·Vito Enrico Pettorossi, (unknown), Pierangelo Errico, Francesco Draicchio, Silvio Dionisotti	10
19	Relation of Dosing Regimen to Aminoglycoside Ototoxicity: Evaluation of Auditory Damage in the Guinea Pig 1990 ·Chemotherapy ·(unknown), Silvio Dionisotti, (unknown), Ennio Ongini, (unknown), Giulio Melone	18
20	High-performance liquid chromatographic determination of netilmicin in guinea-pig and human serum by fluorodinitrobenzene derivatization with spectrophotometric detection 1988 ·Journal of Chromatography B Biomedical Sciences and Applications ·Silvio Dionisotti, (unknown), (unknown), Ennio Ongini	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact